

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proteasome assembly (GO:0043248) | 5.25649381 |
| 2 | cullin deneddylation (GO:0010388) | 4.88838965 |
| 3 | * negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.87353351 |
| 4 | * positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.62945348 |
| 5 | purine nucleobase biosynthetic process (GO:0009113) | 4.62005261 |
| 6 | * regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.56913653 |
| 7 | protein deneddylation (GO:0000338) | 4.54966645 |
| 8 | formation of translation preinitiation complex (GO:0001731) | 4.52729856 |
| 9 | * anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.50288037 |
| 10 | nucleobase biosynthetic process (GO:0046112) | 4.45445282 |
| 11 | * negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.42961131 |
| 12 | * negative regulation of ligase activity (GO:0051352) | 4.42961131 |
| 13 | * regulation of cellular amino acid metabolic process (GO:0006521) | 4.36989726 |
| 14 | * DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.31293228 |
| 15 | * intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.24119627 |
| 16 | * signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.24119627 |
| 17 | * signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.21065773 |
| 18 | * signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.21065773 |
| 19 | * signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.21065773 |
| 20 | histone exchange (GO:0043486) | 4.15970467 |
| 21 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.14517262 |
| 22 | maturation of SSU-rRNA (GO:0030490) | 4.14315565 |
| 23 | DNA double-strand break processing (GO:0000729) | 4.13229274 |
| 24 | * signal transduction involved in DNA damage checkpoint (GO:0072422) | 4.11422737 |
| 25 | * signal transduction involved in DNA integrity checkpoint (GO:0072401) | 4.11422737 |
| 26 | * signal transduction involved in cell cycle checkpoint (GO:0072395) | 4.07044977 |
| 27 | DNA replication initiation (GO:0006270) | 4.06447134 |
| 28 | * positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 4.03005270 |
| 29 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.01708430 |
| 30 | * antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.99451970 |
| 31 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.99368534 |
| 32 | 7-methylguanosine mRNA capping (GO:0006370) | 3.96953504 |
| 33 | ribosome assembly (GO:0042255) | 3.92163000 |
| 34 | 7-methylguanosine RNA capping (GO:0009452) | 3.90697476 |
| 35 | RNA capping (GO:0036260) | 3.90697476 |
| 36 | DNA strand elongation (GO:0022616) | 3.90696693 |
| 37 | ribosomal small subunit assembly (GO:0000028) | 3.88637148 |
| 38 | DNA replication checkpoint (GO:0000076) | 3.87844665 |
| 39 | protein neddylation (GO:0045116) | 3.85878605 |
| 40 | * positive regulation of ligase activity (GO:0051351) | 3.84697476 |
| 41 | ribosome biogenesis (GO:0042254) | 3.82567393 |
| 42 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.80517857 |
| 43 | ribosomal large subunit biogenesis (GO:0042273) | 3.76197628 |
| 44 | CENP-A containing nucleosome assembly (GO:0034080) | 3.76194224 |
| 45 | termination of RNA polymerase III transcription (GO:0006386) | 3.75683167 |
| 46 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.75683167 |
| 47 | * antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.73911346 |
| 48 | mitotic metaphase plate congression (GO:0007080) | 3.72285933 |
| 49 | ATP synthesis coupled proton transport (GO:0015986) | 3.71906601 |
| 50 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.71906601 |
| 51 | protein localization to kinetochore (GO:0034501) | 3.70507243 |
| 52 | * G1/S transition of mitotic cell cycle (GO:0000082) | 3.69375745 |
| 53 | * cell cycle G1/S phase transition (GO:0044843) | 3.69375745 |
| 54 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.68184492 |
| 55 | telomere maintenance via recombination (GO:0000722) | 3.66866380 |
| 56 | DNA ligation (GO:0006266) | 3.65053713 |
| 57 | establishment of viral latency (GO:0019043) | 3.63073671 |
| 58 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.62298882 |
| 59 | chromatin remodeling at centromere (GO:0031055) | 3.59577028 |
| 60 | DNA damage response, detection of DNA damage (GO:0042769) | 3.58334020 |
| 61 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.57266104 |
| 62 | * regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.56794660 |
| 63 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.56245824 |
| 64 | rRNA modification (GO:0000154) | 3.56050497 |
| 65 | establishment of integrated proviral latency (GO:0075713) | 3.46581332 |
| 66 | rRNA processing (GO:0006364) | 3.46419787 |
| 67 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.46331794 |
| 68 | spliceosomal snRNP assembly (GO:0000387) | 3.45858542 |
| 69 | * regulation of ligase activity (GO:0051340) | 3.43477131 |
| 70 | pseudouridine synthesis (GO:0001522) | 3.41617410 |
| 71 | termination of RNA polymerase I transcription (GO:0006363) | 3.40361456 |
| 72 | * positive regulation of cell cycle arrest (GO:0071158) | 3.40286942 |
| 73 | mitotic recombination (GO:0006312) | 3.39318706 |
| 74 | ribosomal small subunit biogenesis (GO:0042274) | 3.36366133 |
| 75 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.35206597 |
| 76 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.35206597 |
| 77 | * DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.35166538 |
| 78 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.34986036 |
| 79 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.34329579 |
| 80 | mitotic sister chromatid segregation (GO:0000070) | 3.34298852 |
| 81 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.32611008 |
| 82 | rRNA metabolic process (GO:0016072) | 3.32224755 |
| 83 | transcription from RNA polymerase I promoter (GO:0006360) | 3.31357636 |
| 84 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.31259850 |
| 85 | maturation of 5.8S rRNA (GO:0000460) | 3.31053881 |
| 86 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.30702768 |
| 87 | spindle checkpoint (GO:0031577) | 3.30379047 |
| 88 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.27480393 |
| 89 | IMP biosynthetic process (GO:0006188) | 3.26608480 |
| 90 | cellular component biogenesis (GO:0044085) | 3.26537338 |
| 91 | DNA deamination (GO:0045006) | 3.25474147 |
| 92 | mitotic spindle checkpoint (GO:0071174) | 3.20732329 |
| 93 | viral mRNA export from host cell nucleus (GO:0046784) | 3.20686558 |
| 94 | telomere maintenance via telomere lengthening (GO:0010833) | 3.18056222 |
| 95 | kinetochore organization (GO:0051383) | 3.17595010 |
| 96 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.16397968 |
| 97 | negative regulation of sister chromatid segregation (GO:0033046) | 3.16397968 |
| 98 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.16397968 |
| 99 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.16397968 |
| 100 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.16397968 |
| 101 | chaperone-mediated protein transport (GO:0072321) | 3.16192261 |
| 102 | regulation of centriole replication (GO:0046599) | 3.15697338 |
| 103 | establishment of protein localization to mitochondrion (GO:0072655) | 3.15344457 |
| 104 | * regulation of cellular amine metabolic process (GO:0033238) | 3.15318110 |
| 105 | translation (GO:0006412) | 3.13571164 |
| 106 | negative regulation of chromosome segregation (GO:0051985) | 3.12996493 |
| 107 | replication fork processing (GO:0031297) | 3.12616992 |
| 108 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.12461249 |
| 109 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.12461249 |
| 110 | spliceosomal complex assembly (GO:0000245) | 3.11876271 |
| 111 | regulation of mitochondrial translation (GO:0070129) | 3.11791110 |
| 112 | sister chromatid segregation (GO:0000819) | 3.11144779 |
| 113 | de novo protein folding (GO:0006458) | 3.10895934 |
| 114 | protein targeting to mitochondrion (GO:0006626) | 3.10252534 |
| 115 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.09891527 |
| 116 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.09891527 |
| 117 | DNA replication-independent nucleosome organization (GO:0034724) | 3.09346793 |
| 118 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.09346793 |
| 119 | metaphase plate congression (GO:0051310) | 3.08122935 |
| 120 | protein localization to chromosome, centromeric region (GO:0071459) | 3.08069926 |
| 121 | DNA unwinding involved in DNA replication (GO:0006268) | 3.07908275 |
| 122 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.07249770 |
| 123 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.07249770 |
| 124 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.06544636 |
| 125 | * antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.05215990 |
| 126 | establishment of chromosome localization (GO:0051303) | 3.05102562 |
| 127 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 3.04216011 |
| 128 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 3.04017689 |
| 129 | kinetochore assembly (GO:0051382) | 3.03351214 |
| 130 | IMP metabolic process (GO:0046040) | 3.00608760 |
| 131 | protein K6-linked ubiquitination (GO:0085020) | 3.00315697 |
| 132 | mitotic spindle assembly checkpoint (GO:0007094) | 2.98940253 |
| 133 | regulation of chromosome segregation (GO:0051983) | 2.97324620 |
| 134 | spindle assembly checkpoint (GO:0071173) | 2.96696707 |
| 135 | protein localization to mitochondrion (GO:0070585) | 2.96502804 |
| 136 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.93018797 |
| 137 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.93018797 |
| 138 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.92829711 |
| 139 | * negative regulation of protein ubiquitination (GO:0031397) | 2.92674064 |
| 140 | histone mRNA metabolic process (GO:0008334) | 2.90704683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.60363821 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.74630018 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.34100577 |
| 4 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.12655269 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.09846610 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.80598768 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.67821859 |
| 8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.62494169 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.52023947 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.39404746 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.33745152 |
| 12 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 3.13034336 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.05861963 |
| 14 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.03289692 |
| 15 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.98781611 |
| 16 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.91504448 |
| 17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.83859572 |
| 18 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.79771172 |
| 19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.74265001 |
| 20 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.54750665 |
| 21 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.50627261 |
| 22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.49828469 |
| 23 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.44956971 |
| 24 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.40426483 |
| 25 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.36328958 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.35992703 |
| 27 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.35732703 |
| 28 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.34195006 |
| 29 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.29526103 |
| 30 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.19358748 |
| 31 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.17830964 |
| 32 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.14744702 |
| 33 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.10216432 |
| 34 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07808228 |
| 35 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.01714496 |
| 36 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.99476445 |
| 37 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.98689899 |
| 38 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.96023703 |
| 39 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.95966503 |
| 40 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.93603444 |
| 41 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.93440770 |
| 42 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.90646503 |
| 43 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.87445600 |
| 44 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.85600169 |
| 45 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.79034635 |
| 46 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.78423448 |
| 47 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.74952561 |
| 48 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.70797173 |
| 49 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.60537150 |
| 50 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.55130007 |
| 51 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.51579975 |
| 52 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.48989869 |
| 53 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.46177022 |
| 54 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.42280779 |
| 55 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.40378339 |
| 56 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.39611630 |
| 57 | VDR_22108803_ChIP-Seq_LS180_Human | 1.37006630 |
| 58 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.25188640 |
| 59 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.24722089 |
| 60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.21816780 |
| 61 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.20534886 |
| 62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19076200 |
| 63 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.18400502 |
| 64 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.17638773 |
| 65 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.16630555 |
| 66 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15897924 |
| 67 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.12527185 |
| 68 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.11825285 |
| 69 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.11423427 |
| 70 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.08396166 |
| 71 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.07207533 |
| 72 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.06842815 |
| 73 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.06838475 |
| 74 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.05055864 |
| 75 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.03751238 |
| 76 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.03589600 |
| 77 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01332712 |
| 78 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01254109 |
| 79 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99389561 |
| 80 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.99116885 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97701897 |
| 82 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.97009802 |
| 83 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.95650647 |
| 84 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.93558747 |
| 85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.91908797 |
| 86 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.90735175 |
| 87 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.88175638 |
| 88 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.88071966 |
| 89 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.86786967 |
| 90 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.86075296 |
| 91 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.85575167 |
| 92 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.85319833 |
| 93 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.83673608 |
| 94 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.83360332 |
| 95 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.81481202 |
| 96 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.80973734 |
| 97 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.80888820 |
| 98 | EWS_26573619_Chip-Seq_HEK293_Human | 0.80588709 |
| 99 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.80424186 |
| 100 | P300_19829295_ChIP-Seq_ESCs_Human | 0.75417267 |
| 101 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.74271757 |
| 102 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.74255814 |
| 103 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.72949954 |
| 104 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.72743258 |
| 105 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.72667867 |
| 106 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.72450578 |
| 107 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.72441753 |
| 108 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.72010860 |
| 109 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70029753 |
| 110 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.69973275 |
| 111 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.68864513 |
| 112 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.68765302 |
| 113 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.67973074 |
| 114 | FUS_26573619_Chip-Seq_HEK293_Human | 0.67935765 |
| 115 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.67858867 |
| 116 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.67388476 |
| 117 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.66785049 |
| 118 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.65132707 |
| 119 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.65055958 |
| 120 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.64590408 |
| 121 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.64375348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.54224662 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.67773095 |
| 3 | MP0010094_abnormal_chromosome_stability | 4.34304074 |
| 4 | MP0003111_abnormal_nucleus_morphology | 3.89215734 |
| 5 | MP0008057_abnormal_DNA_replication | 3.76658160 |
| 6 | MP0003077_abnormal_cell_cycle | 3.71225445 |
| 7 | MP0008058_abnormal_DNA_repair | 3.51412588 |
| 8 | MP0008932_abnormal_embryonic_tissue | 3.19623133 |
| 9 | MP0003123_paternal_imprinting | 2.87933817 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.69367121 |
| 11 | MP0003718_maternal_effect | 2.66962094 |
| 12 | MP0003786_premature_aging | 2.47207425 |
| 13 | MP0008007_abnormal_cellular_replicative | 2.45835494 |
| 14 | MP0001529_abnormal_vocalization | 2.22223735 |
| 15 | MP0008877_abnormal_DNA_methylation | 2.11523224 |
| 16 | MP0001730_embryonic_growth_arrest | 1.99137899 |
| 17 | MP0003186_abnormal_redox_activity | 1.96090774 |
| 18 | MP0006035_abnormal_mitochondrial_morpho | 1.90197661 |
| 19 | MP0000350_abnormal_cell_proliferation | 1.81332920 |
| 20 | MP0002938_white_spotting | 1.78055702 |
| 21 | MP0001293_anophthalmia | 1.74816526 |
| 22 | MP0006072_abnormal_retinal_apoptosis | 1.71583957 |
| 23 | MP0001905_abnormal_dopamine_level | 1.68426860 |
| 24 | MP0009697_abnormal_copulation | 1.66166806 |
| 25 | MP0006036_abnormal_mitochondrial_physio | 1.64117215 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 1.49390184 |
| 27 | MP0002396_abnormal_hematopoietic_system | 1.48503289 |
| 28 | MP0003121_genomic_imprinting | 1.43968447 |
| 29 | MP0008260_abnormal_autophagy | 1.43122098 |
| 30 | MP0003315_abnormal_perineum_morphology | 1.37424623 |
| 31 | MP0003937_abnormal_limbs/digits/tail_de | 1.36253537 |
| 32 | MP0002160_abnormal_reproductive_system | 1.35648800 |
| 33 | MP0003880_abnormal_central_pattern | 1.34002471 |
| 34 | MP0009379_abnormal_foot_pigmentation | 1.33956199 |
| 35 | MP0002163_abnormal_gland_morphology | 1.30838046 |
| 36 | MP0001697_abnormal_embryo_size | 1.30578411 |
| 37 | MP0006276_abnormal_autonomic_nervous | 1.30287260 |
| 38 | MP0002736_abnormal_nociception_after | 1.24818647 |
| 39 | MP0010352_gastrointestinal_tract_polyps | 1.23358647 |
| 40 | MP0002080_prenatal_lethality | 1.23085981 |
| 41 | MP0000372_irregular_coat_pigmentation | 1.22655481 |
| 42 | MP0001542_abnormal_bone_strength | 1.20765544 |
| 43 | MP0000358_abnormal_cell_content/ | 1.20553860 |
| 44 | MP0001672_abnormal_embryogenesis/_devel | 1.19632481 |
| 45 | MP0005380_embryogenesis_phenotype | 1.19632481 |
| 46 | MP0006292_abnormal_olfactory_placode | 1.19394915 |
| 47 | MP0000313_abnormal_cell_death | 1.18672124 |
| 48 | MP0000647_abnormal_sebaceous_gland | 1.14336819 |
| 49 | MP0002735_abnormal_chemical_nociception | 1.14170881 |
| 50 | MP0001727_abnormal_embryo_implantation | 1.09281144 |
| 51 | MP0005394_taste/olfaction_phenotype | 1.08869904 |
| 52 | MP0005499_abnormal_olfactory_system | 1.08869904 |
| 53 | MP0000490_abnormal_crypts_of | 1.08759905 |
| 54 | MP0005389_reproductive_system_phenotype | 1.08646016 |
| 55 | MP0003119_abnormal_digestive_system | 1.07253461 |
| 56 | MP0003984_embryonic_growth_retardation | 1.06698489 |
| 57 | MP0002019_abnormal_tumor_incidence | 1.04780328 |
| 58 | MP0002876_abnormal_thyroid_physiology | 1.03823322 |
| 59 | MP0004147_increased_porphyrin_level | 1.02296717 |
| 60 | MP0003221_abnormal_cardiomyocyte_apopto | 1.02237682 |
| 61 | MP0002088_abnormal_embryonic_growth/wei | 1.02047018 |
| 62 | MP0001286_abnormal_eye_development | 1.01975213 |
| 63 | MP0002751_abnormal_autonomic_nervous | 1.01382139 |
| 64 | MP0009672_abnormal_birth_weight | 1.01345937 |
| 65 | MP0002234_abnormal_pharynx_morphology | 1.01341347 |
| 66 | MP0005253_abnormal_eye_physiology | 1.00926260 |
| 67 | MP0010307_abnormal_tumor_latency | 1.00727268 |
| 68 | MP0003567_abnormal_fetal_cardiomyocyte | 0.98898986 |
| 69 | MP0002233_abnormal_nose_morphology | 0.96633661 |
| 70 | MP0002210_abnormal_sex_determination | 0.96145645 |
| 71 | MP0003890_abnormal_embryonic-extraembry | 0.95287697 |
| 72 | MP0005266_abnormal_metabolism | 0.94169027 |
| 73 | MP0002090_abnormal_vision | 0.91939859 |
| 74 | MP0002111_abnormal_tail_morphology | 0.91616403 |
| 75 | MP0001968_abnormal_touch/_nociception | 0.90672842 |
| 76 | MP0003136_yellow_coat_color | 0.90410524 |
| 77 | MP0002085_abnormal_embryonic_tissue | 0.89770462 |
| 78 | MP0002837_dystrophic_cardiac_calcinosis | 0.87677566 |
| 79 | MP0002697_abnormal_eye_size | 0.87557869 |
| 80 | MP0004215_abnormal_myocardial_fiber | 0.86750157 |
| 81 | MP0002132_abnormal_respiratory_system | 0.84593683 |
| 82 | MP0002102_abnormal_ear_morphology | 0.83859943 |
| 83 | MP0001919_abnormal_reproductive_system | 0.83623759 |
| 84 | MP0001986_abnormal_taste_sensitivity | 0.82951203 |
| 85 | MP0001188_hyperpigmentation | 0.82601915 |
| 86 | MP0003122_maternal_imprinting | 0.81147351 |
| 87 | MP0005084_abnormal_gallbladder_morpholo | 0.79569643 |
| 88 | MP0005384_cellular_phenotype | 0.78891887 |
| 89 | MP0004808_abnormal_hematopoietic_stem | 0.77553494 |
| 90 | MP0003195_calcinosis | 0.77000834 |
| 91 | MP0005391_vision/eye_phenotype | 0.76062431 |
| 92 | MP0001145_abnormal_male_reproductive | 0.75366488 |
| 93 | MP0000015_abnormal_ear_pigmentation | 0.75362880 |
| 94 | MP0001764_abnormal_homeostasis | 0.74339406 |
| 95 | MP0001853_heart_inflammation | 0.74138892 |
| 96 | MP0003755_abnormal_palate_morphology | 0.73379426 |
| 97 | MP0005408_hypopigmentation | 0.72596985 |
| 98 | MP0009703_decreased_birth_body | 0.72309924 |
| 99 | MP0003938_abnormal_ear_development | 0.71779720 |
| 100 | MP0002084_abnormal_developmental_patter | 0.71434154 |
| 101 | MP0006054_spinal_hemorrhage | 0.71157657 |
| 102 | MP0001299_abnormal_eye_distance/ | 0.70895228 |
| 103 | MP0004197_abnormal_fetal_growth/weight/ | 0.70870742 |
| 104 | MP0001177_atelectasis | 0.69688624 |
| 105 | MP0002095_abnormal_skin_pigmentation | 0.69238142 |
| 106 | MP0010030_abnormal_orbit_morphology | 0.68806123 |
| 107 | MP0001485_abnormal_pinna_reflex | 0.68245155 |
| 108 | MP0000049_abnormal_middle_ear | 0.67573984 |
| 109 | MP0000579_abnormal_nail_morphology | 0.67012619 |
| 110 | MP0001984_abnormal_olfaction | 0.66598870 |
| 111 | MP0005187_abnormal_penis_morphology | 0.66173678 |
| 112 | MP0002086_abnormal_extraembryonic_tissu | 0.65847571 |
| 113 | MP0002332_abnormal_exercise_endurance | 0.64773393 |
| 114 | MP0004133_heterotaxia | 0.64669959 |
| 115 | MP0003698_abnormal_male_reproductive | 0.64082405 |
| 116 | MP0008789_abnormal_olfactory_epithelium | 0.63870240 |
| 117 | MP0005367_renal/urinary_system_phenotyp | 0.63839161 |
| 118 | MP0000516_abnormal_urinary_system | 0.63839161 |
| 119 | MP0003941_abnormal_skin_development | 0.62410221 |
| 120 | MP0000749_muscle_degeneration | 0.62191915 |
| 121 | MP0005075_abnormal_melanosome_morpholog | 0.61828582 |
| 122 | MP0005551_abnormal_eye_electrophysiolog | 0.61782678 |
| 123 | MP0001929_abnormal_gametogenesis | 0.61635032 |
| 124 | MP0002398_abnormal_bone_marrow | 0.61528805 |
| 125 | MP0000631_abnormal_neuroendocrine_gland | 0.60990100 |
| 126 | MP0004142_abnormal_muscle_tone | 0.60104634 |
| 127 | MP0000653_abnormal_sex_gland | 0.59374622 |
| 128 | MP0000689_abnormal_spleen_morphology | 0.59297419 |
| 129 | MP0005621_abnormal_cell_physiology | 0.58690402 |
| 130 | MP0002722_abnormal_immune_system | 0.57614889 |
| 131 | MP0002148_abnormal_hypersensitivity_rea | 0.56331768 |
| 132 | MP0003656_abnormal_erythrocyte_physiolo | 0.56276805 |
| 133 | MP0005395_other_phenotype | 0.56223644 |
| 134 | MP0005376_homeostasis/metabolism_phenot | 0.53931632 |
| 135 | MP0005397_hematopoietic_system_phenotyp | 0.53688668 |
| 136 | MP0001545_abnormal_hematopoietic_system | 0.53688668 |
| 137 | MP0001119_abnormal_female_reproductive | 0.53308426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 5.37732136 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.80888466 |
| 3 | Increased serum pyruvate (HP:0003542) | 4.72454269 |
| 4 | Abnormality of glycolysis (HP:0004366) | 4.72454269 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.37428051 |
| 6 | Mitochondrial inheritance (HP:0001427) | 4.14503893 |
| 7 | Increased CSF lactate (HP:0002490) | 3.94499017 |
| 8 | Progressive macrocephaly (HP:0004481) | 3.94003506 |
| 9 | Cerebral hypomyelination (HP:0006808) | 3.82618654 |
| 10 | Breast hypoplasia (HP:0003187) | 3.70017190 |
| 11 | Acute encephalopathy (HP:0006846) | 3.65633996 |
| 12 | Hepatocellular necrosis (HP:0001404) | 3.58095202 |
| 13 | Abnormality of the labia minora (HP:0012880) | 3.44963187 |
| 14 | Increased hepatocellular lipid droplets (HP:0006565) | 3.27306059 |
| 15 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.20817971 |
| 16 | Increased serum lactate (HP:0002151) | 3.19559528 |
| 17 | Carpal bone hypoplasia (HP:0001498) | 3.02389132 |
| 18 | Oral leukoplakia (HP:0002745) | 3.01001039 |
| 19 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.00908977 |
| 20 | 3-Methylglutaconic aciduria (HP:0003535) | 2.98233849 |
| 21 | Hepatic necrosis (HP:0002605) | 2.97976871 |
| 22 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.97539033 |
| 23 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.97539033 |
| 24 | Irregular epiphyses (HP:0010582) | 2.96917826 |
| 25 | Abnormal number of erythroid precursors (HP:0012131) | 2.96118539 |
| 26 | Rough bone trabeculation (HP:0100670) | 2.95496726 |
| 27 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.92594781 |
| 28 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.83280915 |
| 29 | Exercise intolerance (HP:0003546) | 2.78778570 |
| 30 | Methylmalonic aciduria (HP:0012120) | 2.76815378 |
| 31 | Lipid accumulation in hepatocytes (HP:0006561) | 2.75061951 |
| 32 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.71502499 |
| 33 | Volvulus (HP:0002580) | 2.66647003 |
| 34 | Patellar aplasia (HP:0006443) | 2.65942641 |
| 35 | Abnormality of the anterior horn cell (HP:0006802) | 2.65261792 |
| 36 | Degeneration of anterior horn cells (HP:0002398) | 2.65261792 |
| 37 | Type I transferrin isoform profile (HP:0003642) | 2.59184393 |
| 38 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.52474598 |
| 39 | Abnormality of alanine metabolism (HP:0010916) | 2.52474598 |
| 40 | Hyperalaninemia (HP:0003348) | 2.52474598 |
| 41 | Respiratory failure (HP:0002878) | 2.51925031 |
| 42 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.51507015 |
| 43 | Postnatal microcephaly (HP:0005484) | 2.51215745 |
| 44 | Methylmalonic acidemia (HP:0002912) | 2.49691032 |
| 45 | Macrocytic anemia (HP:0001972) | 2.48651127 |
| 46 | Reticulocytopenia (HP:0001896) | 2.48343837 |
| 47 | Lactic acidosis (HP:0003128) | 2.47937153 |
| 48 | Aplastic anemia (HP:0001915) | 2.44693490 |
| 49 | Cerebral edema (HP:0002181) | 2.44606320 |
| 50 | Abnormality of methionine metabolism (HP:0010901) | 2.44262181 |
| 51 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.44045319 |
| 52 | Respiratory difficulties (HP:0002880) | 2.42785864 |
| 53 | Agnosia (HP:0010524) | 2.41467743 |
| 54 | Microvesicular hepatic steatosis (HP:0001414) | 2.38979204 |
| 55 | Abnormality of the preputium (HP:0100587) | 2.38573951 |
| 56 | Renal Fanconi syndrome (HP:0001994) | 2.36720104 |
| 57 | Leukodystrophy (HP:0002415) | 2.32959618 |
| 58 | Absent epiphyses (HP:0010577) | 2.30448943 |
| 59 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.30448943 |
| 60 | CNS hypomyelination (HP:0003429) | 2.28296066 |
| 61 | Abnormal trabecular bone morphology (HP:0100671) | 2.26995179 |
| 62 | Exertional dyspnea (HP:0002875) | 2.24747144 |
| 63 | Hyperglycinemia (HP:0002154) | 2.22685204 |
| 64 | Abnormality of the duodenum (HP:0002246) | 2.22375425 |
| 65 | Abnormality of serum amino acid levels (HP:0003112) | 2.19943530 |
| 66 | Cortical dysplasia (HP:0002539) | 2.15931279 |
| 67 | CNS demyelination (HP:0007305) | 2.12409228 |
| 68 | Stenosis of the external auditory canal (HP:0000402) | 2.11497827 |
| 69 | Glossoptosis (HP:0000162) | 2.11433852 |
| 70 | Microretrognathia (HP:0000308) | 2.11075133 |
| 71 | Emotional lability (HP:0000712) | 2.10880837 |
| 72 | Meckel diverticulum (HP:0002245) | 2.10709095 |
| 73 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.09627358 |
| 74 | Abnormal hair whorl (HP:0010721) | 2.09087332 |
| 75 | Secondary amenorrhea (HP:0000869) | 2.08901780 |
| 76 | Premature graying of hair (HP:0002216) | 2.08231822 |
| 77 | Cellular immunodeficiency (HP:0005374) | 2.07057990 |
| 78 | Abnormal lung lobation (HP:0002101) | 2.06781070 |
| 79 | Absent radius (HP:0003974) | 2.06573661 |
| 80 | Delusions (HP:0000746) | 2.06488115 |
| 81 | Chromsome breakage (HP:0040012) | 2.04691610 |
| 82 | Pallor (HP:0000980) | 2.04459806 |
| 83 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.03798824 |
| 84 | Embryonal renal neoplasm (HP:0011794) | 2.03687405 |
| 85 | Trismus (HP:0000211) | 2.01786777 |
| 86 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.00668303 |
| 87 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.00668303 |
| 88 | Abnormal protein glycosylation (HP:0012346) | 2.00668303 |
| 89 | Abnormal glycosylation (HP:0012345) | 2.00668303 |
| 90 | Selective tooth agenesis (HP:0001592) | 1.99799907 |
| 91 | Sloping forehead (HP:0000340) | 1.99249171 |
| 92 | Abnormality of the ileum (HP:0001549) | 1.98744115 |
| 93 | Bone marrow hypocellularity (HP:0005528) | 1.97842630 |
| 94 | Poor head control (HP:0002421) | 1.97520270 |
| 95 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.97010054 |
| 96 | Optic disc pallor (HP:0000543) | 1.95228606 |
| 97 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.94769416 |
| 98 | Increased intramyocellular lipid droplets (HP:0012240) | 1.94662039 |
| 99 | Autoamputation (HP:0001218) | 1.94419083 |
| 100 | Colon cancer (HP:0003003) | 1.92697170 |
| 101 | Megaloblastic anemia (HP:0001889) | 1.92213818 |
| 102 | Ependymoma (HP:0002888) | 1.91914851 |
| 103 | Horseshoe kidney (HP:0000085) | 1.91399454 |
| 104 | Cleft eyelid (HP:0000625) | 1.91125980 |
| 105 | Absent thumb (HP:0009777) | 1.91111388 |
| 106 | Abnormality of chromosome stability (HP:0003220) | 1.90592544 |
| 107 | Hypoplastic pelvis (HP:0008839) | 1.90538579 |
| 108 | Neoplasm of the adrenal gland (HP:0100631) | 1.89472433 |
| 109 | Absent forearm bone (HP:0003953) | 1.88916942 |
| 110 | Aplasia involving forearm bones (HP:0009822) | 1.88916942 |
| 111 | Premature ovarian failure (HP:0008209) | 1.87669467 |
| 112 | Lethargy (HP:0001254) | 1.87614750 |
| 113 | Reduced antithrombin III activity (HP:0001976) | 1.85910691 |
| 114 | Small intestinal stenosis (HP:0012848) | 1.85662484 |
| 115 | Duodenal stenosis (HP:0100867) | 1.85662484 |
| 116 | Abnormality of placental membranes (HP:0011409) | 1.85180174 |
| 117 | Amniotic constriction ring (HP:0009775) | 1.85180174 |
| 118 | Supernumerary spleens (HP:0009799) | 1.84828858 |
| 119 | Multiple enchondromatosis (HP:0005701) | 1.84499948 |
| 120 | Sparse eyelashes (HP:0000653) | 1.83969093 |
| 121 | Parakeratosis (HP:0001036) | 1.82476489 |
| 122 | Triphalangeal thumb (HP:0001199) | 1.81503654 |
| 123 | Abnormality of the carotid arteries (HP:0005344) | 1.79060343 |
| 124 | Type 2 muscle fiber atrophy (HP:0003554) | 1.79025694 |
| 125 | Unsteady gait (HP:0002317) | 1.77564149 |
| 126 | Increased nuchal translucency (HP:0010880) | 1.77529648 |
| 127 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.75247868 |
| 128 | Myelodysplasia (HP:0002863) | 1.75101678 |
| 129 | Neuroendocrine neoplasm (HP:0100634) | 1.73858604 |
| 130 | Tongue fasciculations (HP:0001308) | 1.73604933 |
| 131 | Congenital, generalized hypertrichosis (HP:0004540) | 1.73049617 |
| 132 | Adrenal hypoplasia (HP:0000835) | 1.71919683 |
| 133 | Pancytopenia (HP:0001876) | 1.71084903 |
| 134 | Medulloblastoma (HP:0002885) | 1.70018108 |
| 135 | Neoplasm of the colon (HP:0100273) | 1.66999787 |
| 136 | Rhabdomyosarcoma (HP:0002859) | 1.66755924 |
| 137 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.64159303 |
| 138 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.62618370 |
| 139 | Abnormality of glycine metabolism (HP:0010895) | 1.62618370 |
| 140 | Pancreatic fibrosis (HP:0100732) | 1.61976965 |
| 141 | Intestinal atresia (HP:0011100) | 1.61880671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.06003077 |
| 2 | EIF2AK1 | 3.91004745 |
| 3 | WEE1 | 3.82725818 |
| 4 | STK16 | 3.39396320 |
| 5 | TSSK6 | 3.14038166 |
| 6 | EIF2AK3 | 2.85033162 |
| 7 | VRK2 | 2.71835147 |
| 8 | TRIM28 | 2.68875049 |
| 9 | SRPK1 | 2.45691017 |
| 10 | NME2 | 2.44419425 |
| 11 | PBK | 2.41474791 |
| 12 | CDC7 | 2.35159360 |
| 13 | BRSK2 | 2.25691965 |
| 14 | PLK4 | 2.11001530 |
| 15 | NEK1 | 1.98564108 |
| 16 | NME1 | 1.98429790 |
| 17 | VRK1 | 1.98283814 |
| 18 | PLK3 | 1.97869442 |
| 19 | MAP3K12 | 1.90840107 |
| 20 | CCNB1 | 1.90304056 |
| 21 | MKNK1 | 1.85632241 |
| 22 | TESK2 | 1.79205888 |
| 23 | NUAK1 | 1.72713312 |
| 24 | ACVR1B | 1.66644824 |
| 25 | MST4 | 1.60127036 |
| 26 | WNK3 | 1.55165593 |
| 27 | PIM2 | 1.54051845 |
| 28 | BRSK1 | 1.50201268 |
| 29 | PLK1 | 1.46163361 |
| 30 | CASK | 1.45594132 |
| 31 | PLK2 | 1.38976844 |
| 32 | TTK | 1.38033776 |
| 33 | ARAF | 1.37398951 |
| 34 | BCR | 1.36648560 |
| 35 | LIMK1 | 1.33322064 |
| 36 | BRAF | 1.23755863 |
| 37 | TAF1 | 1.22780201 |
| 38 | ZAK | 1.20695468 |
| 39 | AURKA | 1.16214502 |
| 40 | MKNK2 | 1.15326464 |
| 41 | AURKB | 1.08652743 |
| 42 | MAP3K4 | 1.06698923 |
| 43 | EIF2AK2 | 1.06373212 |
| 44 | TLK1 | 1.05911480 |
| 45 | MAP4K2 | 1.04874459 |
| 46 | TNIK | 1.04606112 |
| 47 | TESK1 | 1.03248963 |
| 48 | AKT3 | 1.01421247 |
| 49 | CSNK1G1 | 1.00390865 |
| 50 | CSNK1G2 | 0.95219224 |
| 51 | NEK2 | 0.94993859 |
| 52 | EPHA2 | 0.94953999 |
| 53 | ATR | 0.87351347 |
| 54 | PASK | 0.85748071 |
| 55 | CHEK2 | 0.85726801 |
| 56 | ERBB3 | 0.83472857 |
| 57 | TGFBR1 | 0.82164422 |
| 58 | CSNK1A1L | 0.81506269 |
| 59 | PNCK | 0.80054792 |
| 60 | DYRK2 | 0.79727368 |
| 61 | RPS6KB2 | 0.78823042 |
| 62 | ERBB4 | 0.77116822 |
| 63 | DYRK3 | 0.73141620 |
| 64 | CDK8 | 0.72646298 |
| 65 | CDK19 | 0.71228494 |
| 66 | ADRBK2 | 0.69614215 |
| 67 | CSNK2A1 | 0.69524839 |
| 68 | STK39 | 0.68610111 |
| 69 | SIK3 | 0.68166129 |
| 70 | CSNK2A2 | 0.67792503 |
| 71 | CDK7 | 0.66528711 |
| 72 | RPS6KA4 | 0.65502309 |
| 73 | BMPR2 | 0.62504978 |
| 74 | DAPK1 | 0.60139602 |
| 75 | CHEK1 | 0.59481353 |
| 76 | ABL2 | 0.59387764 |
| 77 | PDK4 | 0.57654997 |
| 78 | PDK3 | 0.57654997 |
| 79 | PAK1 | 0.57178432 |
| 80 | STK3 | 0.57089090 |
| 81 | ALK | 0.55278463 |
| 82 | PAK4 | 0.50859144 |
| 83 | BCKDK | 0.49282203 |
| 84 | YES1 | 0.49123524 |
| 85 | STK4 | 0.48151018 |
| 86 | RPS6KA5 | 0.47476187 |
| 87 | FGFR1 | 0.46752315 |
| 88 | CDK14 | 0.46685746 |
| 89 | CDK18 | 0.46145724 |
| 90 | STK10 | 0.45920313 |
| 91 | MAP3K8 | 0.44996175 |
| 92 | TIE1 | 0.44589433 |
| 93 | PRKCI | 0.43959098 |
| 94 | MAP2K7 | 0.42662566 |
| 95 | CSNK1E | 0.41210229 |
| 96 | STK24 | 0.38966823 |
| 97 | CSNK1G3 | 0.38906216 |
| 98 | CDK15 | 0.38717303 |
| 99 | PIM1 | 0.38318236 |
| 100 | MYLK | 0.38313508 |
| 101 | CLK1 | 0.36223016 |
| 102 | PDK2 | 0.36052051 |
| 103 | IRAK4 | 0.35643747 |
| 104 | CDK11A | 0.34932265 |
| 105 | GRK5 | 0.34731594 |
| 106 | CDK1 | 0.33757235 |
| 107 | CDK2 | 0.33547152 |
| 108 | WNK4 | 0.33250248 |
| 109 | BMPR1B | 0.33135349 |
| 110 | FRK | 0.33019391 |
| 111 | SCYL2 | 0.32818677 |
| 112 | ATM | 0.32683956 |
| 113 | STK38L | 0.32467337 |
| 114 | LATS1 | 0.31144483 |
| 115 | GRK1 | 0.31117768 |
| 116 | TXK | 0.31016687 |
| 117 | MINK1 | 0.29261633 |
| 118 | MAPK13 | 0.28991674 |
| 119 | MAP3K11 | 0.28746821 |
| 120 | PRKCG | 0.27992843 |
| 121 | CDK3 | 0.27437692 |
| 122 | NEK6 | 0.26533379 |
| 123 | PRKDC | 0.26531821 |
| 124 | KDR | 0.24380436 |
| 125 | OXSR1 | 0.22888176 |
| 126 | GRK7 | 0.22687826 |
| 127 | TAOK2 | 0.22582046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Proteasome_Homo sapiens_hsa03050 | 5.63230427 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.94758788 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 3.80043995 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.66343003 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.50002777 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 3.37234494 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.81273033 |
| 8 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.71031728 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 2.71010257 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.68803043 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.52587079 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 2.50973114 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.37999211 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 2.31786815 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.21448986 |
| 16 | Cell cycle_Homo sapiens_hsa04110 | 2.01975729 |
| 17 | Basal transcription factors_Homo sapiens_hsa03022 | 1.94387940 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.91064475 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89298500 |
| 20 | Protein export_Homo sapiens_hsa03060 | 1.80620213 |
| 21 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.69516376 |
| 22 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.69470471 |
| 23 | RNA degradation_Homo sapiens_hsa03018 | 1.56152953 |
| 24 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.52255159 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.50007819 |
| 26 | Purine metabolism_Homo sapiens_hsa00230 | 1.47957077 |
| 27 | Alzheimers disease_Homo sapiens_hsa05010 | 1.45190529 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.36219041 |
| 29 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.34068209 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.32556458 |
| 31 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.24306965 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.19865047 |
| 33 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.14067295 |
| 34 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.13674041 |
| 35 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.13550228 |
| 36 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.10138284 |
| 37 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.08206065 |
| 38 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03817517 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.96544811 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.96430885 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.88093006 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.87237690 |
| 43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.84566462 |
| 44 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.82610048 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.79588774 |
| 46 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77473230 |
| 47 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.77075869 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.75539563 |
| 49 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.70342682 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 0.66592927 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.64817197 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.64325272 |
| 53 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.62642400 |
| 54 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.62289181 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 0.62135079 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 0.60972764 |
| 57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.58643040 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 0.58601846 |
| 59 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.56684290 |
| 60 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55062933 |
| 61 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54886008 |
| 62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53942592 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52072138 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51450303 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.51370858 |
| 66 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.51092089 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50307422 |
| 68 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.50244774 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49154827 |
| 70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47569296 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45403795 |
| 72 | Phototransduction_Homo sapiens_hsa04744 | 0.44884618 |
| 73 | Allograft rejection_Homo sapiens_hsa05330 | 0.44691127 |
| 74 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.44250533 |
| 75 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.43899551 |
| 76 | Shigellosis_Homo sapiens_hsa05131 | 0.42509891 |
| 77 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.40103318 |
| 78 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39903353 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39708147 |
| 80 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.39518843 |
| 81 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39503282 |
| 82 | Asthma_Homo sapiens_hsa05310 | 0.39448601 |
| 83 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39009205 |
| 84 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38929682 |
| 85 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.38005566 |
| 86 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.37714317 |
| 87 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.37303242 |
| 88 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.36783445 |
| 89 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.34619611 |
| 90 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33988111 |
| 91 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.33621366 |
| 92 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.33519980 |
| 93 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.32582285 |
| 94 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.31887411 |
| 95 | Alcoholism_Homo sapiens_hsa05034 | 0.30366883 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.29842304 |
| 97 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.28786291 |
| 98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.27383902 |
| 99 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.24531038 |
| 100 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.24339425 |
| 101 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.23167583 |
| 102 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.19565738 |
| 103 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.19197450 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.18955592 |
| 105 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.18791855 |
| 106 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.18752229 |
| 107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.17066214 |
| 108 | Retinol metabolism_Homo sapiens_hsa00830 | 0.15317367 |
| 109 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.14783151 |
| 110 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.14015754 |
| 111 | Apoptosis_Homo sapiens_hsa04210 | 0.13447777 |
| 112 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.13241827 |
| 113 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.12310009 |
| 114 | Thyroid cancer_Homo sapiens_hsa05216 | 0.11546993 |
| 115 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.11219850 |
| 116 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.10852578 |
| 117 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.10799566 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.09801790 |
| 119 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.08166987 |
| 120 | Measles_Homo sapiens_hsa05162 | 0.07853655 |
| 121 | Tight junction_Homo sapiens_hsa04530 | 0.07635066 |
| 122 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.06922672 |
| 123 | Sulfur relay system_Homo sapiens_hsa04122 | 0.06915724 |
| 124 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.05092655 |
| 125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.04853882 |
| 126 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.04314431 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.03455966 |
| 128 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.03370730 |
| 129 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.02954367 |
| 130 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.02901174 |
| 131 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.02539738 |
| 132 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.02531922 |

